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DEGREES AND VARIATIONS IN IMMUNOGLOBULIN RESPONSES 
IN INFECTIOUS HEPATITIS 
GERALD A. LOGRIPPO, M.D.*, NANSIE S. SHARPLESS, M.SC.** 
AND H A J I M E HAYASHI, P H . D . * * * 
INTRODUCTION 
In a previous report, data were presented on an institutional outbreak of infectious 
hepatitis in children.' The purpose of this communication is to detail the degree and 
variations of immunoglobulin responses found among hepatitis patients with clinical 
jaundice, elevated serum transaminase values, or both. These findings put a different 
hght on the complications and chronicity of this disease. In addition, they suggest the 
potential value of passive immunity in the course of therapy for individuals who are 
immunologically depressed or incompetent 
MATERIALS AND METHODS 
Quantitation of Serum Immunoglobulins. The procedure for determining serum 
immunoglobulins (Ig) is one developed, standardized and reported from this labo-
ratory.^ Essentially a micro double-diffusion technic using agar slides, it employs the 
Ouchterlony principle. Monoimmune antiserum for each of the three immunoglobulins 
is obtained from commercial sources. The values are expressed in mg/100 ml of 
serum. The normal adult range of variation (two standard deviations from the mean) 
for the respective immunoglobulinst are IgA (30-135 mg/100 ml) ; IgM (40-120 
mg/100 ml) ; and IgG (600-1400 mg/100 ml) . The ages of patients in this study 
are from 1 to 15 years. The normal range of immunoglobulin values for this age 
group approximates that given for adults. These data are being prepared for pubhcation. 
Qualitation of Immunoglobulin-G. Serum neutralizing antibody titers to 8-12 
enteric viruses were used to determine the quality of IgG. In a previous publication 
the standards developed for their usage have been described in detail." The enteric 
viruses also serve to determine whether specific antibodies, present during the acute 
stage of the disease, decrease four to eightfold or more following 30 to 60 days (half-
life or more of IgG turnover) after onset of the disease.' (The upper respiratory 
*Chief, Division of Microbiology, Department of Laboratories. 
**Technical Assistant, Immunochemistry Section of Microbiology. 
**Research Associate, 'Virology Section of Microbiology. 
tNomenclature adopted by WHO Committee, Prague, 1964.3 
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viruses have not been found satisfactory for this purpose since they do not persist 
throughout the years as do the enteric viruses.") In addition, every effort was made to 
isolate any virus agent from the individual patients to determine the time sequence 
for a fourfold sero-conversion and whether antibody titer would develop for the 
individual's own virus isolate.' 
Patient Source: An acute outbreak of infectious hepatitis occurred at Plymouth 
State Home and Training School, an institution for mentally retarded children, at 
Northville, Michigan. Among 652 inmates, 87 children had the chnical signs and 
symptoms of infectious hepatitis. However, inadequate serum collection and serum 
volume for immunoglobulin determinations limited this report to 64 cases. Among 
these, all but nine children had clinical jaundice, elevated serum glutamic pyruvic 
transaminase (SGPT), or both. The nine patients were included in the evaluation 
because of their signs and symptoms and the degree of immunoglobulin responses, 
which were consistently elevated. It should be made clear that the six cases with 
immunodepression (Table 2) are not among the nine who had no record of jaundice 
or transaminase values. 
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RESULTS 
Considerable variation exists in the total number of patients included in the 
different statistical analyses of the results, because serum was not available on all 
the patients for all four periods of study. Only those patients were included on 
whom serum evaluations were available for at least three of the four periods. The 
majority of patients, however, had serum evaluations for all four periods of study. 
Excluded from the report were patients who had only one or two evaluations. 
The abruptness of the outbreak of infectious hepatitis and the variations in 
individual responses is shown in Figure 1. The manifestations of clinical jaundice 
and serum glutamic pyruvic transaminase (SGPT) elevations in relation to the im-
munoglobulin-M responses are emphasized. Two cases had records of jaundice without 
transaminase elevations or IgM response; 11 cases showed elevated SGPT only; 4 
showed jaundice with elevated SGPT; 18 showed elevated SGPT and elevated IgM; 
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19 demonstrated elevated SGPT, elevated IgM, and jaundice. Nine demonstrated 
elevated IgM with clinical signs and symptoms of hepatitis, but no data were available 
on SGPT levels or possible jaundice. The fact that the majority of the cases occurred 
during a four-week period, August 24th to September 14th, supports the concept 
of a common etiological agent. 
•Values for the three major classes of immunoglobulins (IgA, IgM and IgG) 
were determined for all the patients by immunochemical analysis.^ Since IgA was 
not significantly altered in any of the patients during the six-month period of study, 
these values are not included in this report. The degree of IgM response over the 
entire period is shown in a scattergram (Figure 2) . The normal range (2 standard 
deviations from the mean) for IgM is between 40-120 mg/100 ml of serum. The 
IgM values are highest during the acute stage of the disease, 83% of the cases showing 
an elevation above 2 S.D. of the normal range. Although there were several patients 
with a very high degree of IgM response, the majority showed an elevation of 100 
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to 200% above the 2 S.D. of normal variation. The IgM values are elevated in 
41% of the children after the first month; 38% after the fourth month; and 33% 
after six to seven months. The discrepancy in the total number of cases in each 
period of study arises from the number of serum specimens available during the 
different periods. 
The degree of IgG response is seen in the accompanying scattergram (Figure 3). 
The overall picture obtained from the data is that, over the six months of study, 
IgG values which are lowest during the acute stage of the disease gradually increase 
after 1, 4 and 6-7 months, rising as high as 50% to 150% increase above the 
normal 2 S.D. range for IgG variations. Also, it is true that in the majority of 
patients the IgG values rose as the IgM values declined. The totals given at the 
bottom of the scattergram for each period produce a false impression of a constantiy 
elevated IgG value in the majority of patients, the discrepancy being due again to 
the number of available specimens. 
The individual variations in the immunoglobulin responses over the six months 
of study fall roughly into five groups. Figure 4 illustrates this for IgM. Out of 
48 patients, 10 fell into Group A. In these ten cases, the IgM average values were 
above two standard deviations during the acute stage and they remained elevated at 
one, four, and six month periods of study. In Group B, 17 patients were found to 
have IgM average values above two standard deviations during the acute stage. 
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but they returned to normal within one to four months. In Group C, only two 
patients lagged in their IgM response. However, their IgM values did ri.se above 
the two standard deviations within one to four months, and remained elevated at 
seven months. In Group D, eight patients showed average IgM responses which 
oscillated from values above two standard deviations to the normal range during 
the six-month period. In Group E, 11 patients had IgM responses which never 
did rise above the two standard deviation values. 
The relationship of IgG responses to IgM responses is shown in Table 1. The 
five groups of individual responses were also found in the IgG values. To show 
the true relationship between IgG and IgM responses in detail the following code 
was devised and used in Table I . The large letters from "A" to "E" represent the 
groups just described for IgM responses. The small letters from "a" to "e" indicate 
the same groups of responses for IgG. The arrows indicate immunoglobulin responses 
above the normal range of two standard deviations. The letter " N " indicates values 
within the normal range of variation. Any or all of the five IgG probabilities may 
be found with each of the five IgM groups. The numerals in the squares represent 
the number of patients showing the type of IgG response associated with the indicated 
IgM group. The majority of patients respond with an IgG value indicated by "a" 
(that group in which the IgG is commonly elevated above two standard deviations 
during the acute stage of the disease, and remains elevated for at least six months 
after onset of the disease). This "a" group of IgG responses is, however, spread 
TABLE I 
GROUP VARIATIONS OF IMMUNOGLOBULIN (Ig) RESPONSE IN CHILDREN 
WITH INFECTIOUS HEPATITIS DURING FOUR PERIODS OF STUDY 
IgM Response* Patients a IgG Response* Total 
Patients Gps. Acute Months 
1 4 6-7 
ll II II, II II II II ,ii II II 
a b c d e 
i t-N N-i i \ N 
A 1 1 1 1 6 1 1 1 1 10 
B r ~-^ N 9 1 1 1 5 17 
C ^ 1 t 0 0 1 1 0 2 
D t N t Nt 5 0 2 1 0 8 
E N N N N 5 0 1 1 4 1 1 
48 
* 1 Indicates Ig values above normal range of standard variations (2 S. D.). 
N Indicates Ig values within normal range. 
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throughout the five corresponding IgM responses. The other variations do occur in 
a small number of patients, stressing the individuality of the variation of immuno-
globulin responses. The 10 patients listed under IgG column "e" represent a rather 
large percentage of patients not responding with IgG values of a significantly elevated 
degree. Here again, the IgG "e" group response is spread throughout the corre-
sponding IgM response groups. 
Immuno-depression was demonstrated in 6 of the 64 children studied. Immuno-
depression was based on two findings: (a) loss within 1-4 months of significant 
quantities of specific neutralizing antibodies to enteric viruses present in high titers 
during the acute stage of the disease; and (b) lack of response with specific serum 
neutralizing antibodies to active infections of the gastrointestinal tract during the 
icteric stage which was shown by excretion of live virus in the stool. The effect of 
infectious hepatitis on antibody response to enteric virus infections as demonstrated 
in these 6 patients has been published elsewhere.' In the present study these 6 patients 
have been separated into the categories set forth in Table I . The correlation between 
the categories into which these patients fall and the variations and degrees of their 
immunoglobulin responses is shown in Table I I . Of the 6 patients, 4 showed no 
IgM increase during the four periods of study; of the 4 patients, two failed to show 
any IgG increase, one demonstrated a delayed increase, which appeared by the 
fourth period of study, and one demonstrated a slight increase in IgG throughout 
the four periods. Of the remaining two patients, one showed the usual IgM response 
and an elevation of IgG throughout the four periods of study; the other showed 
IgM values which oscillated from increased to normal values while the IgG remained 
markedly elevated during the entire four periods. The varying immunoglobulin 
responses obtained in these 6 patients with definite immuno-depression emphasize 
the necessity of determining the quality as well as the quantity of the immune 
response and the necessity of evaluating each patient individually. 
TABLE I I 
INFECTIOUS HEPATITIS 
Variations and Degrees in Immunoglobulin (Ig) Responses 
in Patients with Immuno Depression 
Relationship: S T A G E OF H E P A T I T I S 
Patient IgM to IgG Acute 1 mo. 4 mo. 6-7 mo. Acute 1 mo. 4 mo. 6-7 mo. 
Number Variations* Ig- M (40-120mg/100 n i l ) * * Ig-G (600-1400mg/100ml)** 
26 E-e 
-
97 
-
91 
-
1, 123 
--
1, 199 
31 E-e 78 63 68 
-
899 628 848 
--
38 E-c 48 
-
35 56 1, 152 
-
1, 344 1, 730 t 
51 E-a 64 81 81 72 1, 587t 1, 920l 1, 472 t 1, 847 t 
4 B-a 250t 150 t 68 79 2, 283 t 2, 182t 1, 478 t 1. 843 \ 
7 D-a 368 t 109 125 t 120 3, 042 t 2. 906t 3, 552 t 3, 426 t 
* Immunologic categories described in Tahle-I. 
** Normal range of variation (mean + 2 S. D. ). 
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DISCUSSION 
The degrees and variations of immunoglobulin responses found among 64 cases 
of infectious hepatitis offer a new explanation for the complexities of this disease. 
The large and confusing hterature on the complications and sequelae have not been 
explained on the basis of varying etiological agents, and clinical, laboratory and 
pathological manifestations. The common denominator may well be the "immunological 
status of the individual' and his specific ability to cope with intercurrent infections 
and endotoxemias. The degrees and variations in the immunologic status of the 
individual may now be quantitated and immunoglobulin-G-i?«a//fare£/ as well. It 
remains to correlate, if possible, these findings with the final outcome of the disease. 
What is the immunoglobulin response of the patient who recovers completely as con-
trasted with the immunoglobulin response of the patient who progresses into a chronic 
state or remains a carrier? In a previous communication' it was postulated that the 
primary disease may well be in the reticuloendothelial system and the damage to the 
hver secondary to an endotoxemia acquired during an immunodepressive state. The 
data also showed an immunodepressive state in 10% of the children. It lasted for a 
period of at least six months (the duration of the study period). The degrees and 
variations in immunoglobulin responses presented in this paper together with the 
evidence presented in previous communications''' strongly support the view that the 
complications and sequelae seen in this disease may not be due to the primary infection 
per se in the hver. They may very well represent a reaction to any number of inter-
current infections and endotoxemic states subsequent to the varying degrees of immuno-
depression and lack of immune response (globulin dyscrasia)This deficiency can 
be in the form of the quantity or quality of the immunoglobulin components, or both, 
as evidenced from the data presented from this laboratory.''*'' 
On the basis of the five variations in IgM responses (Groups A to E) and the 
related IgG responses shown in Table I , it appears more logical to interpret the 
clinical complications and sequelae of this disease on the individual's immune status. 
Although it is tempting to speculate which variety of immune response is responsible 
for the different complications known, this is not possible with the data available. For 
example, one cannot postulate whether individuals in the IgM Group A are hepatitis 
carriers because of a persistence of antigenic stimulation (demonstrated by an elevated 
IgM), or whether individuals in IgM Group E continue to shed active hepatitis virus 
(i.e. are carriers) because of an incompetent immune mechanism. In an attempt to 
explain why IgM persists, one or two possibilities may be postulated: either the IgM 
stimulation is from the hepatitis virus per se or from such stimulants as gram negative 
endotoxins whose presence is due to an immuno-depressive state of the reticuloendo-
thelial system. However, until the hepatitis agent(s) becomes available as a practical 
laboratory tool, the variations and degrees of immunoglobulin responses can only be 
correlated roughly with clinical complications and sequelae associated with the respec-
tive responses. Moreover, new methods are required to determine which complications 
are due to virus action and which are due to intercurrent infections and endotoxins. 
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With a better understanding of the immunologic status of the hepatitis patient, 
justification for passive immunity therapy or prophylaxis is demonstrated. Hepatitis 
free plasma''^' or gamma globulin should be useful dependent upon whether immuno-
depression, immunoglobulin deficiency or immunoglobulin dyscrasia is demonstrated; 
determination of the specific condition being possible with our methods of analysis. 
SUMMARY 
Of 87 cases of infectious hepatitis, 64 were studied to correlate the degrees and 
variations of immunoglobulin (Ig) responses in serum. The 64 cases were selected 
on the basis of clinical jaundice, elevated serum, glutamic pyruvic transaminase levels 
above 40 units/ml of serum, or both. IgA values were not significantiy affected during 
the four periods of study. The degree of IgM increases varied from 100% to 600%, 
and IgG from 50% to 150% above the upper limits of normal values. The immuno-
globulin values were compared during the acute stage, and at one, four, and six-to-
seven months thereafter. The variations in IgM and IgG responses in hepatitis patients 
are grouped into five categories: (1) those with persistent elevations beyond seven 
months; (2) those returning to normal in one to four months; (3) those oscillating 
between elevated and normal values; (4) those with delayed responses; and (5) those 
with no rise in IgM or IgG values above the normal range of variation. From the data 
available it is not possible to come to any predictable conclusion as to the Ig responses 
in patients with infectious hepatitis. The variations in responses indicate that the 
immunoglobulin status must be determined on an individual basis. A state of immuno-
depression in 10% of the patients during the stages of the disease gives rise to interest-
ing speculations, though, here again, no definite conclusions can be reached. 
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